Reply: Granisetron vs ondansetron: is it a question of duration of 5-HT3 receptor blockade?

Abstract

British Journal of Cancer (2002) 86, 1664–1664. DOI: 10.1038/sj/bjc/6600314 www.bjcancer.co

    Similar works

    Available Versions

    Last time updated on 11/12/2019